Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Assets Average (2016 - 2025)

Utah Medical Products has reported Assets Average over the past 15 years, most recently at $122.3 million for Q4 2025.

  • Quarterly results put Assets Average at $122.3 million for Q4 2025, down 3.06% from a year ago — trailing twelve months through Dec 2025 was $122.3 million (down 3.06% YoY), and the annual figure for FY2025 was $122.5 million, down 5.01%.
  • Assets Average for Q4 2025 was $122.3 million at Utah Medical Products, up from $121.4 million in the prior quarter.
  • Over the last five years, Assets Average for UTMD hit a ceiling of $135.4 million in Q1 2024 and a floor of $113.1 million in Q1 2021.
  • Median Assets Average over the past 5 years was $122.0 million (2025), compared with a mean of $123.5 million.
  • Biggest five-year swings in Assets Average: grew 12.31% in 2021 and later dropped 9.54% in 2025.
  • Utah Medical Products' Assets Average stood at $117.7 million in 2021, then increased by 2.93% to $121.1 million in 2022, then grew by 10.08% to $133.4 million in 2023, then fell by 5.43% to $126.1 million in 2024, then fell by 3.06% to $122.3 million in 2025.
  • The last three reported values for Assets Average were $122.3 million (Q4 2025), $121.4 million (Q3 2025), and $121.7 million (Q2 2025) per Business Quant data.